Tag Archives: informed consent
JAMA Internal Medicine | Perioperative Use of Selective Serotonin Reuptake Inhibitors and Risks for Adverse Outcomes of SurgeryPerioperative SSRI Use and Adverse Outcome Risk
Full Content is available to subscribers Subscribe/Learn More Original Investigation | ONLINE FIRST Perioperative Use of Selective Serotonin Reuptake Inhibitors and Risks for Adverse Outcomes of Surgery Andrew D. Auerbach, MD, MPH; Eric Vittinghoff, PhD; Judith Maselli, MSPH; Penelope S. … Continue reading →
Adults with depression and who take specific anti-depressants more likely to develop C. difficile
Interesting applied psychoimmunology study. Apparently depressed people’s guts don’t watch direct-to-consumer chemical-imbalance ads. Here is the abstract. Depression, antidepressant medications, and risk of Clostridium difficile infection Mary A M Rogers1*, M Todd Greene1, Vincent B Young1, Sanjay Saint1,2, Kenneth M … Continue reading →
How the FDA forgot the evidence: the case of donepezil 23 mg | BMJ
BMJ Observations Not So Stories How the FDA forgot the evidence: the case of donepezil 23 mg BMJ 2012; 344 doi: http://dx.doi.org.ezproxy.cul.columbia.edu/10.1136/bmj.e1086 (Published 22 March 2012) Cite this as: BMJ 2012;344:e1086 Lisa M Schwartz, professor12, Steven Woloshin, professor12 Author Affiliations … Continue reading →
Ben Goldacre: What doctors don’t know about the drugs they prescribe | Video on TED.com
Ben Goldacre: What doctors don’t know about the drugs they prescribe | Video on TED.com Continue reading →
Cancer risk in multiple sclerosis: findings from British Columbia, Canada.
Good news but probably offset by use of immune-modulating/suppressive interventions (especially of cellular immunity) for MS. Do neurologists explain that to their patients? Another study to be done. Brain. 2012 Oct;135(Pt 10):2973-9. doi: 10.1093/brain/aws148. Epub 2012 Jun 21. Cancer risk … Continue reading →